SCHEMBL7558786

SCHEMBL7558786

Cc1ccc2[nH]c(=O)c(C(=O)N(C)c3ccc(F)cc3F)c(O)c2c1C=S

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 1/20 0.41
KDM4E B2RXH2 2/20 0.33
HSD17B1 P14061 2/20 0.32
HSD17B2 P37059 2/20 0.32
PIK3C3 Q8NEB9 2/20 0.32
DAO P14920 1/20 0.32
HTR1A P08908 1/20 0.32
HTR2A P28223 1/20 0.32
HTR7 P34969 1/20 0.32
HTR6 P50406 1/20 0.32
GSK3B P49841 1/20 0.32
KDM5A P29375 1/20 0.31
PARP1 P09874 1/20 0.31
MAPK1 P28482 1/20 0.31
NPSR1 Q6W5P4 1/20 0.31
RXFP1 Q9HBX9 1/20 0.31
PADI4 Q9UM07 1/20 0.30
MEN1 O00255 1/20 0.30
KMT2A Q03164 1/20 0.30
PIK3CA P42336 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7556667 0.92 HSD17B1 (0.34) MAPTKDM4EHSD17B1HSD17B2DAO
SCHEMBL7557389 0.85 MAPT (0.43) MAPTKDM4EHSD17B1HSD17B2PIK3C3
SCHEMBL7558377 0.84 MAPT (0.42) MAPTKDM4EHSD17B1HSD17B2PIK3C3
SCHEMBL7559768 0.83 MAPT (0.48) MAPTKDM4EHSD17B1HSD17B2PIK3C3
SCHEMBL7559757 0.83 MAPT (0.39) MAPTHSD17B1HSD17B2PIK3C3HTR1A
SCHEMBL7862448 0.80 KMT2A (0.38) MAPTKDM4EKDM5ARXFP1PADI4
SCHEMBL7593043 0.78 HDAC4 (0.42) MAPTKDM5A
SCHEMBL7563319 0.77 HTR1A (0.36) MAPTKDM4EHSD17B1HSD17B2DAO
SCHEMBL7558487 0.77 MAPT (0.41) MAPTKDM4EHSD17B1HSD17B2PIK3C3
SCHEMBL7557878 0.76 MAPT (0.39) MAPTHSD17B1HSD17B2PIK3C3KDM5A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1224172-A1 DRUGS FOR THE TREATMENT OF MALIGNANT TUMOURS Active Biotech AB (SE) 2002-07-24 EP claimed
EP-1097139-A1 QUINOLINE DERIVATIVES Active Biotech AB (SE) 2001-05-09 EP claimed
WO-2001030758-A1 DRUGS FOR THE TREATMENT OF MALIGNANT TUMOURS ACTIVE BIOTECH AB (SE) 2001-05-03 WO claimed
WO-2000003992-A1 QUINOLINE DERIVATIVES ACTIVE BIOTECH AB (SE) 2000-01-27 WO claimed
EP-1224172-A1 DRUGS FOR THE TREATMENT OF MALIGNANT TUMOURS Active Biotech AB (SE) 2002-07-24 EP disclosed
EP-1097139-A1 QUINOLINE DERIVATIVES Active Biotech AB (SE) 2001-05-09 EP disclosed
WO-2001030758-A1 DRUGS FOR THE TREATMENT OF MALIGNANT TUMOURS ACTIVE BIOTECH AB (SE) 2001-05-03 WO disclosed
WO-2000003992-A1 QUINOLINE DERIVATIVES ACTIVE BIOTECH AB (SE) 2000-01-27 WO disclosed